Accelerate Diagnostics Inc 's ability to collect its outstanding accounts receivable from its corporate clients, has improved in the fourth quarter 2024 to a ratio of 5.17, above the company average. This is a clear sign of healthy business climate in the Laboratory Analytical Instruments industry and improving liquidity at their respective customers, during the fourth quarter 2024. Average receivable collection period, for the Accelerate Diagnostics Inc in Dec 31 2024 quarter, has decreased to 71 days, compared to 74 days, in the Sep 30 2024 quarter.

If we take a look into Healthcare sector 359 other companies have achieved higher receivables turnover ratio. While total ranking has deteriorated relative to the period ending Dec 31 2024 from 1798 to 2513.

What is Receivable Turnover Ratio?
What is Accelerate Diagnostics Inc Selling?

What is Receivable Turnover Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Accounts Receivables Turnover▼

None ▼

Accounts Receivables Turnover▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

AXDX Receivables Turnover Ratio	(Dec 31 2024) IV. Quarter	(Sep 30 2024) III. Quarter	(Jun 30 2024) II. Quarter	(Mar 31 2024) I. Quarter	(Dec 31 2023) IV. Quarter
Y / Y Receivable Change	-22.31 %	-23.97 %	-2.26 %	-8.65 %	8.53 %
Y / Y Revenue Change	-6.97 %	157.99 %	-4.39 %	-3.17 %	1.82 %
Receivable Turnover Ratio (TTM)	5.17	4.93	3.89	3.92	3.88
AXDX's Total Ranking	# 2513	# 1798	# 1801	# 2527	# 2219
Accounts Receivable average collection period days	71	74	94	93	94
Seq. Receivable Change	0.49 %	-11.45 %	3.25 %	-15.45 %	-1.65 %
Seq. Revenue Change	-1.4 %	6.73 %	-1.73 %	-10.04 %	173.44 %

Receivable Turnover Company Ranking
Within:	No.
Laboratory Analytical Instruments Industry	# 12
Healthcare Sector	# 360
Overall Market	# 2513

Receivable Turnover Ratio Statistics
High	Average	Low
0.38	0.1	0
(Sep 30 2024)		(Sep. 30, 2014)

AXDX Company Profile • Back to AXDX Efficiency Comparisons • Compare AXDX Receivables Turnover Ratio to its Competitors

Financial Statements
Accelerate Diagnostics Inc 's Accounts Receivable	$ 2 Millions	Visit AXDX's Balance sheet
Accelerate Diagnostics Inc 's Sales TTM	$ 11 Millions	Visit AXDX's Income Statement
Sources of AXDX's Revenues		Visit AXDX's Sales by Geography

Other Accounts Receivable Turnover Ratios
Laboratory Analytical Instruments Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
AXDX's Receivable Turnover Ratio versus Laboratory Analytical Instruments Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
AXDX's Growth Rates	AXDX's Roa	AXDX's Inventory Turnover Ratio	AXDX's Dividend Comparisons
AXDX's Profitability Ratios	AXDX's Roi	AXDX's Asset Turnover Ratio	AXDX's Dividend Growth
AXDX's Valuation Ratios	AXDX's Roe	AXDX's Financial Strength Ratios	AXDX's Dividend Payout Ratio

Companies with similar Receivables Turnover Ratio for the quarter ending Dec 31 2024, within Healthcare Sector	Receivable Turnover Ratio	Revenues for 12 Months ending Dec 31 2024	Receivable at quarter ending Dec 31 2024
Biofrontera Inc	14.59	$ 63.395 Millions	$ 4.346 Millions
Icu Medical Inc	14.57	$ 2,382.046 Millions	$ 163.441 Millions
Sangamo Therapeutics Inc	14.13	$ 57.800 Millions	$ 4.092 Millions
Inmed Pharmaceuticals Inc	14.12	$ 4.494 Millions	$ 0.318 Millions
China Pharma Holdings Inc	13.76	$ 4.529 Millions	$ 0.329 Millions
Chemed Corporation	13.32	$ 2,431.287 Millions	$ 182.485 Millions
Qt Imaging Holdings Inc exact Name Of Registrant As Specified In Its Charter _______________________	13.23	$ 4.879 Millions	$ 0.369 Millions
Amylyx Pharmaceuticals Inc	13.13	$ 87.371 Millions	$ 6.655 Millions
Patterson Companies Inc	13.08	$ 6,511.680 Millions	$ 497.898 Millions
Qhslab Inc	12.98	$ 2.132 Millions	$ 0.164 Millions
Nrc Health	12.89	$ 143.060 Millions	$ 11.100 Millions
Rosecliff Acquisition Corp I	12.51	$ 29.581 Millions	$ 2.366 Millions
Spero Therapeutics Inc	12.36	$ 47.977 Millions	$ 3.883 Millions
Co diagnostics Inc	12.07	$ 3.915 Millions	$ 0.324 Millions
Teladoc Health Inc	11.97	$ 2,569.574 Millions	$ 214.724 Millions
Lexicon Pharmaceuticals Inc	11.82	$ 31.081 Millions	$ 2.629 Millions
Quipt Home Medical Corp	11.80	$ 429.306 Millions	$ 36.385 Millions
Corcept Therapeutics Inc	11.79	$ 675.040 Millions	$ 57.262 Millions
Dyadic International Inc	11.71	$ 3.495 Millions	$ 0.299 Millions
Integrated Biopharma Inc	11.57	$ 52.074 Millions	$ 4.500 Millions
Absci Corp	11.44	$ 4.534 Millions	$ 0.397 Millions
International Stem Cell Corporation	11.43	$ 9.085 Millions	$ 0.795 Millions
Scorpius Holdings inc	11.34	$ 6.243 Millions	$ 0.550 Millions
Lifeloc Technologies Inc	11.34	$ 8.538 Millions	$ 0.753 Millions
Protalix Biotherapeutics inc	11.25	$ 53.399 Millions	$ 4.747 Millions
Concentra Group Holdings Parent Inc	11.20	$ 1,900.192 Millions	$ 169.721 Millions
Longeveron Inc	11.13	$ 2.392 Millions	$ 0.215 Millions
Exact Sciences Corporation	10.95	$ 2,788.463 Millions	$ 254.559 Millions
Myomo Inc	10.94	$ 32.185 Millions	$ 2.941 Millions
Newamsterdam Pharma Company N v	10.88	$ 45.563 Millions	$ 4.188 Millions

Date modified: 2026-06-22T14:32:39+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.